Leucine-rich repeat transmembrane protein 2 (LRRTM2) emerged as a key protein associated with both SGLT2 inhibition and HF, and the results showed that SGLT2 inhibition decreased the risk of HF. This evidence concerns the gene LRRTM2 and hydrops fetalis.